Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00943423 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

Study acronym: RAPID
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Study completion date: Dec 2030 to Dec 2028v8
  3. Re-verified, no change to tracked fieldsv7
  4. Study completion date: Dec 2015 to Dec 2030v6
  5. Primary completion date changed from estimate of Dec 2015 to Jul 2014v5
Show 3 earlier versionsHide 3 earlier versions
  1. Lead sponsor: The Christie NHS Foundation Trust to University College, Londonv4 Show 8 more changesShow less
    • Primary completion date: Dec 2009 to Dec 2015
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 400 to confirmed 602
    • Study completion date: Dec 2015
    • Interventions: clinical observation (Other), radiation therapy (Radiation) to Involved Field Radiotherapy (Radiation), No further treatment (Other)
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised
    • Collaborators expanded, about 5 words
  2. Interventions: observation (Procedure), radiation therapy (Radiation) to clinical observation (Other), radiation therapy (Radiation)v3
  3. Study description expanded, about 5 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RATIONALE: A PET scan may help doctors learn how the cancer responded to combination chemotherapy and whether radiation therapy is also required. PURPOSE: This randomized phase III trial is studying giving a PET scan to see how well it works in deciding whether patients who have received combination chemotherapy for stage IA or stage IIA Hodgkin lymphoma also need radiation therapy.
Trial Details
NCT Number NCT00943423
Lead Sponsor University College, London
Collaborators: The Christie NHS Foundation Trust
Conditions
(from sponsor)		 Lymphoma
Related terms Hodgkin Disease, Lymphoma
Enrollment 602 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov